Smooth Muscle Pharmacology & Molecular Pharmacology Laboratory, Department of Veterinary Pharmacology & Toxicology, College of Veterinary Science and Animal Husbandry, Uttar Pradesh Pandit Deen Dayal Upadhyaya Pashu Chikitsa Vigyan Vishwavidyalaya Evam Go-Anusandhan Sansthan (DUVASU), Mathura, India.
J Recept Signal Transduct Res. 2023 Dec;43(2):37-49. doi: 10.1080/10799893.2023.2204960. Epub 2023 Apr 26.
Hyporeactivity to vasopressors leading to multiple organ failure is a serious clinical implication in sepsis. Though the regulatory role of purinoceptors in inflammation is reported, their involvement in sepsis-induced vasoplegia is still unknown. Thus we investigated the effect of sepsis on vascular AT1 and PY receptors.
Polymicrobial sepsis was induced by cecal ligation and puncture in mice. Vascular reactivity was assessed by organ bath study and aortic mRNA expression of AT1 and PY was quantified by qRT-PCR.
Both angiotensin-II and UDP produced higher contractions in the absence of endothelium as well as following inhibition of nitric oxide synthase. Angiotensin-II mediated aortic contraction was antagonized by losartan (AT1 antagonist), but not by PD123319 (AT2 antagonist) whereas UDP-induced aortic contraction was significantly inhibited by MRS2578 (PY antagonist). In addition, MRS2578 significantly inhibited the contractile response of Ang-II. Compared to SO mice, angiotensin-II and UDP-induced maximum contraction were found to be significantly attenuated in sepsis. Accordingly, aortic mRNA expression of AT1a receptors was significantly down-regulated while that of PY receptors was significantly increased in sepsis. 1400 W (a selective iNOS inhibitor) significantly reversed angiotensin-II-induced vascular hyporeactivity in sepsis without affecting UDP-induced hypo-reactivity.
Sepsis-induced vascular hyporeactivity to angiotensin-II is mediated by enhanced expression of iNOS. Moreover, AT1R-PY cross talk/heterodimerization could be a novel target for regulating vascular dysfunction in sepsis.
血管加压素反应低下导致多器官衰竭是脓毒症的严重临床并发症。尽管嘌呤能受体在炎症中的调节作用已有报道,但它们在脓毒症引起的血管扩张中的作用仍不清楚。因此,我们研究了脓毒症对血管 AT1 和 PY 受体的影响。
通过盲肠结扎和穿刺在小鼠中诱导多微生物脓毒症。通过器官浴研究评估血管反应性,并通过 qRT-PCR 定量主动脉 AT1 和 PY 的 mRNA 表达。
血管紧张素 II 和 UDP 在没有内皮的情况下以及在抑制一氧化氮合酶后均产生更高的收缩。血管紧张素 II 介导的主动脉收缩被 losartan(AT1 拮抗剂)拮抗,但不是 PD123319(AT2 拮抗剂),而 UDP 诱导的主动脉收缩被 MRS2578(PY 拮抗剂)显著抑制。此外,MRS2578 显著抑制了 Ang-II 的收缩反应。与 SO 小鼠相比,在脓毒症中发现血管紧张素 II 和 UDP 诱导的最大收缩明显减弱。因此,在脓毒症中,AT1a 受体的主动脉 mRNA 表达明显下调,而 PY 受体的表达明显上调。1400W(一种选择性 iNOS 抑制剂)在不影响 UDP 诱导的低反应性的情况下,显著逆转了脓毒症中血管紧张素 II 诱导的血管低反应性。
脓毒症引起的血管对血管紧张素 II 的低反应性是由 iNOS 表达增强介导的。此外,AT1R-PY 交叉对话/异二聚体化可能是调节脓毒症中血管功能障碍的一个新靶点。